![]() |
||||
Program<Japanese> |
»[1st day] Oct.25(Tue) »[2nd day] Oct.26(Wed) »[3rd day] Oct.27(Thu) |
(update: 2016.10.4) | ||
|
|||||||||||||||||
| Oct 24 Mon |
Time | 1F | 2F | 5F | 4F | ||||||||||||
| Hall | Fukuju(144) | Togen(144) | Small Hall(250) | Training Room(84) | 401(63) | 402(30) | 403(30) | 406(30) | 407(36) | ||||||||
| 12:45-17:30 | <Tutorial> | ||||||||||||||||
|
|||||||||||||||||
| Oct 25 Tue 1st day |
Time | 1F | 2F | 5F | 4F | ||||||||||||
| Hall | Fukuju(144) | Togen(144) | Small Hall(250) | Training Room(84) | 401(63) | 402(30) | 403(30) | 406(30) | 407(36) | ||||||||
| 10:00-10:30 | <Opening Remarks> Chair: Toichi Takenaka(NIBIOHN/Japan Health Sciences Foundation K-01 Toshio Goto (RIKEN)"Role of In Silico Simulation in Academic Drug Discovery" |
||||||||||||||||
| 10:30-12:00 | <Plenary Lecture> "Drug Discovery in Academics" Chair: Toichi Takenaka(NIBIOHN/Japan Health Sciences Foundation
|
||||||||||||||||
| 12:00-13:30 | <Luncheon Seminar> LS-01 Ryoka Systems Inc. Josep Prous, Jr.(Prous Institute of Biomedical Research) "Increasing Drug R&D Productivity Through Advanced Predictive Analytics Technologies " |
<Luncheon Seminar> LS-02 Thomson Reuters |
|||||||||||||||
| 13:30-14:00 | Poster Session | ||||||||||||||||
| 14:00-15:30 | <Focused Session> FS-03 Smart Healthcare Business and Microbiome Informatics |
<Invited Talk> "Drug Discovery in Academics" Chair:Toshio Goto (RIKEN)
|
Open symposium of Grant-in-Aid for Scientific Research on Innovation Area "Molecular Robotics"
|
<Focused Session> FS-01 Basics of computational toxicology (Multivariate analysis / Pattern recognition and artificial intelligence) |
<Focused Session> FS-02 Oral Presentation (In silico drug discovery) |
||||||||||||
| 15:30-16:00 | Poster Session | ||||||||||||||||
| 16:00-17:30 | <Sponsored Session> "Drug Discovery in Academics" SS-01 --Panel discussion-- Chair: Takayoshi Okabe(The Univ. of Tokyo) Yoishi Kurebayashi(The Japan Agency for Medical Research and Development (AMED)) "Perspectives on Collaborative Drug Discovery in Japan" |
<Focused Session> FS-04 Computational toxicology related research presentations |
<Focused Session> FS-02 Oral Presentation (In silico drug discovery) |
<Sponsor's workshop> Biomodeling Research Co., Ltd. |
<Focused Session> FS-05 Oral Presentation (Molecular recognition and molecular modeling) |
||||||||||||
| 17:30-19:30 | Poster Session | 17:30-18:00 CBI general meeting | 18:00-18:30 CBI Council Meeting | ||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
| Oct 26 Wed 2nd day |
Time | 1F | 2F | 5F | 4F | ||||||||||||
| Hall | Fukuju(144) | Togen(144) | Small Hall(250) | Training Room(84) | 401(63) | 402(30) | 403(30) | 406(30) | 407(36) | ||||||||
| 10:00-11:30 | <Plenary Lecture> Chair: Shigenori Tanaka(Kobe Univ.)
|
||||||||||||||||
| 11:30-13:00 | <Luncheon Seminar> LS-03 Elsevier Japan KK |
<Luncheon Seminar> LS-04 Patcore, Inc. |
CBI2017 Committee | ||||||||||||||
| 13:00-14:00 | Poster Session | ||||||||||||||||
| 14:00-15:30 | <Invited Talk> Chair: Takatsugu Hirokawa(CBRC)
|
Open symposium of Grant-in-Aid for Scientific Research on Innovation Area "Molecular Robotics"
|
<Focused Session> FS-06 Computational toxicology and in silico drug discovery |
<Focused Session> FS-07 The Fourth Working Group Meeting on Omics-based Analysis |
<Focused Session> FS-08 Oral Presentation (Information and computational approach for drug design and ADMET study) |
<Focused Session> FS-09 Structural Biology and Computer Simulation toward Aptamer Pharmaceutical Composition |
|||||||||||
| 15:30-16:00 | Poster Session | ||||||||||||||||
| 16:00-17:30 | <Sponsored Session> SS-02 --Panel discussion-- Chair: Teruki Honma(RIKEN) Yasushi Okuno(Kyoto Univ./RIKEN) |
<Focused Session> FS-10 Computational toxicology related topics (1) |
<Focused Session> FS-11 Frontiers in BioMedPharma&Ntutrition Data to Knowledge Science |
<Sponsor's workshop> Ryoka Systems Inc. |
<Focused Session> FS-08 Oral Presentation (Information and computational approach for drug design and ADMET study) |
||||||||||||
| 17:30-18:30 | Poster Session | CBI Poster Selection Meeting | |||||||||||||||
| 18:30-20:30 | Banquet (Zuiun) | ||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
| Oct 27 Thu 3rd day |
Time | 1F | 2F | 5F | 4F | ||||||||||||
| Hall | Fukuju(144) | Togen(144) | Small Hall(250) | Training Room(84) | 401(63) | 402(30) | 403(30) | 406(30) | 407(36) | ||||||||
| 10:00-11:30 | <Plenary Lecture> "Structural biology
and big data" Chair: Shigeyuki Yokoyama(RIKEN)
|
||||||||||||||||
| 11:30-12:00 | Poster Award | ||||||||||||||||
| 12:00-13:30 | <Luncheon Seminar> LS-05 CRESSET/LEVEL FIVE Co., Ltd./BIOSPIRE JAPAN Ltd. |
<Luncheon Seminar> LS-06 Chem-Bio Informatics Society(CBI) |
CBIJ Editing Committee | ||||||||||||||
| 13:30-15:00 | <Invited Talk>"Structural biology
and big data" Chair: Takeshi Sagara(TAIHO PHARMACEUTICAL)
|
<Public Lecture> "Novel approaches to realize disease prevention and healthcare"
|
<Focused Session> FS-12 Computer Aided Drug Discovery Contest |
<Focused Session> FS-13 Machine learning predictes drug toxicity using stem cell systems |
<Focused Session> FS-14 Advanced Measurement and Analysis |
<Focused Session> FS-15 Information Utilization for Individualized medicine |
|||||||||||
| 15:00-15:30 | Next Meeting Information | ||||||||||||||||
| 15:30-17:00 | <Sponsored Session> Intel K.K. |
<Focused Session> FS-12 Computer Aided Drug Discovery Contest |
<Focused Session> FS-16 Platforms for ADME/Tox prediction Introduction to AMED project “Construction of drug discovery informatics system” |
<Sponsor's workshop> Mizuho Information & Research Institute, Inc. |
<Focused Session> FS-14 Advanced Measurement and Analysis |
||||||||||||
| 17:00-17:15 | Closing Remarks | ||||||||||||||||

K-01 Toshio Goto (RIKEN)
K-02 Tetsuo Noda(Japanese Foundation for Cancer Research(JFCR))
K-03Hiroaki Mitsuya(National Center for Global Health and Medicine/National Cancer Institute
)
I-01 Hiroyuki Seimiya(Japanese Foundation for Cancer Research (JFCR))
I-02 Toshio Miyata(Tohoku Univ.)
I-03 Takashi Kadowaki(The University of Tokyo)
Yoishi Kurebayashi(The Japan Agency for Medical Research and Development (AMED))
K-04 Kazuo Kitaura(Kyoto Univ.)
K-05 Kenneth M. Merz, Jr (Institute for Cyber Enabled Research (iCER), Michigan State Univ.)
I-04 Kaori Fukuzawa(Hoshi Univ.)
I-05 Makoto Taiji(RIKEN)
I-06 Mitsunori Ikeguchi(Yokohama City Univ.)
Yasushi Okuno(Kyoto Univ./RIKEN)
K-06 Tetsuya Ishikawa(RIKEN)
K-07 So Iwata(Kyoto University)
I-07 Mikako Shiromizu(RIKEN)
I-08 Kenji Iwasaki(Institute for Protein Research, Osaka Univ.)
I-09 Kenji Mizuguchi(National Institutes of Biomedical Innovation, Health and Nutrition)
Tsuneaki Gomi(Gomi Clinic)
Takeshi Kaneko(Yokohama City University)
Takeshi Kusunoki(Juntendo University)
Toshihisa Ishikawa(NGO Personalized Medicine & Healthcare)